#2154050
ISIFEITIMÍD
ISOFETAMID
Filter results
Collections
16 results in 7 documents
#2286240
A mhéid a bhaineann le hisifeitimíd, cuireadh iarratas den sórt sin isteach ar thorthaí cána.
As regards isofetamid, such an application was submitted for cane fruits.
#2286375
Isifeitimíd
Isofetamid
#2490023
Isifeitimíd
Isofetamid
#2286233
I gcás aicrinitrine, fluvailionáite, foilpéid, isifeitimíde, spineatoram agus spiriteitreamat, leagadh síos uasleibhéil iarmhar (“MRLanna”) in Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 396/2005.
For acrinathrin, fluvalinate, folpet, isofetamid, spinetoram and spirotetramat, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.
#2286273
EFSA Journal [Iris EFSA] 2021;19(6):6673.Reasoned opinion on the modification of the existing maximum residue levels for isofetamid in raspberries, blackberries and dewberries. [Tuairim réasúnaithe maidir leis na huasleibhéil iarmhar atá ann cheana le haghaidh isifeitimíde i sútha craobh, sméara dubha agus eithreoga a mhodhnú].
EFSA Journal 2021;19(6):6673.Reasoned opinion on the modification of the existing maximum residue levels for isofetamid in raspberries, blackberries and dewberries.
#2286284
in Iarscríbhinn II, cuirtear an méid seo a leanas in ionad na gcolún le haghaidh aicrinitrine, fluvailionáite, foilpéid, isifeitimíde, spineatoram agus spiriteitreamat:
In Annex II, the columns for acrinathrin, fluvalinate, folpet, isofetamid, spinetoram and spirotetramat are replaced by the following:
#2489649
in Iarscríbhinn II, cuirtear an méid seo a leanas in áit na gcolún a bhaineann le beinsivindéfhluipir, boscailid, feanasacuin, fluasafop-P, fluipiridhéfhúrón, floscaipiorocsad, isifeitimíd, meataflumasón, pireaclóstróibin, spiriteitreamat, tiaibeandasól agus tolclófos-meitil:
in Annex II, the columns for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl are replaced by the following:
#2286227
lena leasaítear Iarscríbhinn II, III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar aicrinitrine, fluvailionáite, foilpéid, foiseitile, isifeitimíde, “Víreas Mósáice an Pheipíonó, tréithchineál AE, aonraíoch lag Abp1”, “Víreas Mósáice an Pheipíonó, tréithchineál CH2, aonraíoch lag Abp2”, táirgí spineatoram agus spiriteitreamat i dtáirgí áirithe nó orthu
amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acrinathrin, fluvalinate, folpet, fosetyl, isofetamid, ‘Pepino Mosaic Virus, EU strain, mild isolate Abp1’, ‘Pepino Mosaic Virus, CH2 strain, mild isolate Abp2’, spinetoram and spirotetramat in or on certain products
#2377299
Rialachán (AE) 2022/93 ón gCoimisiún an 20 Eanáir 2022 lena leasaítear Iarscríbhinn II, III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar aicrinitrine, fluvailionáite, foilpéid, foiseitile, isifeitimíde, “Víreas Mósáice an Pheipíonó, tréithchineál Aontais, aonraíoch lag Abp1”, “Víreas Mósáice an Pheipíonó, tréithchineál CH2, aonraíoch lag Abp2”, táirgí spineatoram agus spiriteitreamat i dtáirgí áirithe nó orthu tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2022/93 of 20 January 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acrinathrin, fluvalinate, folpet, fosetyl, isofetamid, ‘Pepino Mosaic Virus, EU strain, mild isolate Abp1’, ‘Pepino Mosaic Virus, CH2 strain, mild isolate Abp2’, spinetoram and spirotetramat in or on certain products is to be incorporated into the EEA Agreement.
#2489610
lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products
#2489616
An 14 Nollaig 2021, ghlac an Coimisiún Codex Alimentarius uasteorainneacha iarmhair nua Codex (CXLanna) le haghaidh aicéiteaclóir, aifidipiripeine, beinsivindéfhluipire, défheintrine, boscailide, búpróifisine, cairbeandaisime, clórantrainileapróil, cioglainileapról, cipirmeitriní (lena n-áirítear alfa-cipirmeitrin agus zéite-cipirmeitrin), díceamba, feanascuine, floiniocaimíd, fluasafop-P, fluansulfóin, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, gliofosáite, isifeitimíd, creasocsaim-meitile, mandastróibine, méisitrí-óin, meataflumasóin, meataconasóil, meitipréine, peindémheatailine, peintiaipiorad, piococsastróibine, própaconasóil, pidhéfhluimeitifeine, pireaclóstróibine, pirióifeanóin, pireaprocsaifeine, spiriteitreamat, teabúconsóil, tiaibeandasóil, tolclófos-meitile agus toilfeinpioráide.
On 14 December 2021, the Codex Alimentarius Commission adopted new Codex maximum residue limits (CXLs) for acetochlor, afidopyropen, benzovindiflupyr, bifenthrin, boscalid, buprofezin, carbendazim, chlorantraniliprole, cyclaniliprole, cypermethrins (including alpha- and zeta- cypermethrin), dicamba, fenazaquin, flonicamid, fluazifop-P, fluensulfone, flupyradifurone, fluxapyroxad, fosetyl-Al, glyphosate, isofetamid, kresoxim-methyl, mandestrobin, mesotrione, metaflumizone, metconazole, methoprene, pendimethalin, penthiopyrad, picoxystrobin, propiconazole, pydiflumetofen, pyraclostrobin, pyriofenone, pyriproxyfen, spirotetramat, tebuconazole, thiabendazole, tolclofos-methyl and tolfenpyrad.
#2489623
Maidir leis na CXLanna nár chuir an tAontas forchoimeádas ina leith faoi bhráid an Choiste Codex maidir le hIarmhair Lotnaidicídí agus nár shainaithin an tÚdarás imní a d’fhéadfadh a bheith ann ina leith maidir le géar-iontógáil, rud a bhaineann le CXLanna áirithe le haghaidh beinsivindéfhluipire, boscailide, feanascuine, fluasafop-P, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, isifeitimíd, meitipréin, pireaclóstróibine, spiriteitreamat, tiaibeandasóil agus tolclófos-meitile.
The CXLs for which the Union did not present a reservation to the Codex Committee on Pesticides Residues and for which the Authority did not identify a potential acute intake concern, which concern certain CXLs for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl, are safe for consumers in the Union.
#2893537
Rialachán (AE) 2022/1324 ón gCoimisiún an 28 Iúil 2022 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2022/1324 of 28 July 2022 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products is to be incorporated into the EEA Agreement.
#3087126
Rialachán (AE) 2020/856 ón gCoimisiún an 9 Meitheamh 2020 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh ciantrainileapróil, ciasófaimíde, ciopróidínile, feinpiorocsamáite, fluidhé-ocsainile, flocsaipiorocsaid, iomasailile, isifeitimíde, creasocsaim-meitile, lúifeanúróin, mandaprópaimíde, própamacarb, pireaclóstróibine, pirióifeanóin, pireaprocsaifeine agus spíonatóraim i dtáirgí áirithe nó ar tháirgí áirithe, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2020/856 of 9 June 2020 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyantraniliprole, cyazofamid, cyprodinil, fenpyroximate, fludioxonil, fluxapyroxad, imazalil, isofetamid, kresoxim-methyl, lufenuron, mandipropamid, propamocarb, pyraclostrobin, pyriofenone, pyriproxyfen and spinetoram in or on certain products is to be incorporated into the EEA Agreement.
#3212334
Rialachán (AE) 2017/171 ón gCoimisiún an 30 Eanáir 2017 lena leasaítear Iarscríbhinní II III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhair le haghaidh aimínipirilide, ciofluifeanaimíde, ciopróconasóil, dé-eatofeancarb, déthiacarbamáite, fluasafop-P, fluaipioraim, halocsafop, isifeitimíde, meatalacsail, próiheicseaidé-óin, própacuiseafoip, pirimeiteanaile, Trichoderma atroviride tréithchineál SC1 agus socsaimíde i dtáirgí áirithe nó ar tháirgí áirithe (IO L 30, 3.2.2017, lch. 45).
Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products (OJ L 30, 3.2.2017, p. 45).